A
ADPT
Adaptive Biotechnologies Corporation Common Stock
$25.62
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Adaptive Biotechnologies Corporation Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$0.41
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
After the close · Expected EPS: -$0.10
Nov 5
Posts
No posts about ADPT yet.
About Adaptive Biotechnologies Corporation Common Stock
Adaptive Biotechnologies reads the immune system's genetic code to learn how the body fights disease. It sells tests and research tools to drug companies and labs, and runs a clinical test that tracks leftover cancer cells in blood after treatment. It also earns money from partnerships with drug makers that use its immune data to develop new medicines.